Sensing of cell death by myeloid C-type lectin receptors

Current Opinion in Immunology

Volumn 25, Issue 1, 2013, Pages 46-52

  Sancho, David ^a   Reis e Sousa, Caetano ^b  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^b THE FRANCIS CRICK INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONIN 60; F ACTIN; HEAT SHOCK PROTEIN 70; LECTIN RECEPTOR; LIPID; MINCLE RECEPTOR; MYELOID C TYPE LECTIN RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PROTEIN DEC 205 RECEPTOR; PROTEIN DNGR 1 RECEPTOR; PROTEIN MGL1 RECEPTOR; RIBONUCLEOPROTEIN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGEN RETRIEVAL; ANTIGENICITY; CELL DAMAGE; CELL DEATH; CELL DEATH SENSING; CELL DETECTION; CELLULAR PARAMETERS; CROSS PRESENTATION; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LIPID OXIDATION; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; TISSUE REPAIR;

ANIMALS; APOPTOSIS; AUTOANTIGENS; ENDOCYTOSIS; HOMEOSTASIS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; IMMUNOMODULATION; LECTINS, C-TYPE; MYELOID CELLS;

EID: 84875242379     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2012.12.007     Document Type: Review

References (52)

1. Galluzzi L., Vitale I., Abrams J.M., Alnemri E.S., Baehrecke E.H., Blagosklonny M.V., Dawson T.M., Dawson V.L., El-Deiry W.S., Fulda S., et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012, 19:107-120.
2. Oka K., Sawamura T., Kikuta K., Itokawa S., Kume N., Kita T., Masaki T. Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells. Proc Natl Acad Sci U S A 1998, 95:9535-9540.
3. Yuita H., Tsuiji M., Tajika Y., Matsumoto Y., Hirano K., Suzuki N., Irimura T. Retardation of removal of radiation-induced apoptotic cells in developing neural tubes in macrophage galactose-type C-type lectin-1-deficient mouse embryos. Glycobiology 2005, 15:1368-1375.
4. Yamasaki S., Ishikawa E., Sakuma M., Hara H., Ogata K., Saito T. Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nat Immunol 2008, 9:1179-1188.
5. Sancho D., Joffre O., Keller A., Rogers N., Martínez D., Hernanz-Falcón P., Rosewell I., Reis e Sousa C. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 2009, 458:899-903.
6. Green D., Ferguson T., Zitvogel L., Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev Immunol 2009, 9:353-363.
7. Drickamer K. C-type lectin-like domains. Curr Opin Struct Biol 1999, 9:585-590.
8. Zelensky A.N., Gready J.E. The C-type lectin-like domain superfamily. FEBS J 2005, 272:6179-6217.
9. Sancho D., Reis e Sousa C. Signaling by myeloid c-type lectin receptors in immunity and homeostasis. Annu Rev Immunol 2012, 30:491-529.
10. Nickel T., Schmauss D., Hanssen H., Sicic Z., Krebs B., Jankl S., Summo C., Fraunberger P., Walli A.K., Pfeiler S., et al. oxLDL uptake by dendritic cells induces upregulation of scavenger-receptors, maturation and differentiation. Atherosclerosis 2009, 205:442-450.
11. Shrimpton R.E., Butler M., Morel A.-S., Eren E., Hue S.S., Ritter M.A. CD205 (DEC-205): a recognition receptor for apoptotic and necrotic self. Mol Immunol 2009, 46:1229-1239.
12. Lahoud M.H., Ahmet F., Zhang J.-G., Meuter S., Policheni A.N., Kitsoulis S., Lee C.-N., apos O., Keeffe M., Sullivan L.C., et al. DEC-205 is a cell surface receptor for CpG oligonucleotides. Proc Natl Acad Sci U S A 2012, 109:16270-16275.
13. Singh S.K., Streng-Ouwehand I., Litjens M., Weelij D.R., García-Vallejo J.J., van Vliet S.J., Saeland E., van Kooyk Y. Characterization of murine MGL1 and MGL2 C-type lectins: distinct glycan specificities and tumor binding properties. Mol Immunol 2009, 46:1240-1249.
14. Xie J., Zhu H., Guo L., Ruan Y., Wang L., Sun L., Zhou L., Wu W., Yun X., Shen A., et al. Lectin-like oxidized low-density lipoprotein receptor-1 delivers heat shock protein 60-fused antigen into the MHC class I presentation pathway. J Immunol 2010, 185:2306-2313.
15. Delneste Y., Magistrelli G., Gauchat J., Haeuw J., Aubry J., Nakamura K., Kawakami-Honda N., Goetsch L., Sawamura T., Bonnefoy J., et al. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 2002, 17:353-362.
16. Zhang J.-G., Czabotar P.E., Policheni A.N., Caminschi I., San Wan S., Kitsoulis S., Tullett K.M., Robin A.Y., Brammananth R., van Delft M.F., et al. The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments. Immunity 2012, 36:646-657.
17. Ahrens S., Zelenay S., Sancho D., Hanč P., Kjær S., Feest C., Fletcher G., Durkin C., Postigo A., Skehel M., et al. F-Actin is an evolutionarily conserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells. Immunity 2012, 36:635-645.
18. Bugarcic A., Hitchens K., Beckhouse A.G., Wells C.A., Ashman R.B., Blanchard H. Human and mouse macrophage-inducible C-type lectin (Mincle) bind Candida albicans. Glycobiology 2008, 18:679-685.
19. Wells C.A., Salvage-Jones J.A., Li X., Hitchens K., Butcher S., Murray R.Z., Beckhouse A.G., Lo Y.-L.-S., Manzanero S., Cobbold C., et al. The macrophage-inducible C-type lectin, mincle, is an essential component of the innate immune response to Candida albicans. J Immunol 2008, 180:7404-7413.
20. Yamasaki S., Matsumoto M., Takeuchi O., Matsuzawa T., Ishikawa E., Sakuma M., Tateno H., Uno J., Hirabayashi J., Mikami Y., et al. C-type lectin Mincle is an activating receptor for pathogenic fungus, Malassezia. Proc Natl Acad Sci U S A 2009, 106:1897-1902.
21. Ishikawa E., Ishikawa T., Morita Y.S., Toyonaga K., Yamada H., Takeuchi O., Kinoshita T., Akira S., Yoshikai Y., Yamasaki S. Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J Exp Med 2009, 206:2879-2888.
22. Huysamen C., Willment J.A., Dennehy K.M., Brown G.D. CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes. J Biol Chem 2008, 283:16693-16701.
23. Zelenay S., Keller A.M., Whitney P.G., Schraml B.U., Deddouche S., Rogers N.C., Schulz O., Sancho D., Reis e Sousa C. The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice. J Clin Invest 2012, 122:1615-1627.
24. Burgdorf S., Kautz A., Böhnert V., Knolle P.A., Kurts C. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 2007, 316:612-616.
25. Joffre O.P., Segura E., Savina A., Amigorena S Cross-presentation by dendritic cells. Nat Rev Immunol 2012, 12:557-569.
26. Belizaire R., Unanue E.R. Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation. Proc Natl Acad Sci U S A 2009, 106:17463-17468.
27. Iborra S., Izquierdo H.M., Martínez-López M., Blanco-Menéndez N., Reis e Sousa C., Sancho D. The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice. J Clin Invest 2012, 122:1628-1643.
28. Schulz O., Diebold S.S., Chen M., Näslund T.I., Nolte M.A., Alexopoulou L., Azuma Y.-T., Flavell R.A., Liljeström P., Reis e Sousa C. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 2005, 433:887-892.
29. Apetoh L., Ghiringhelli F., Tesniere A., Obeid M., Ortiz C., Criollo A., Mignot G., Maiuri M.C., Ullrich E., Saulnier P., et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007, 13:1050-1059.
30. Parlato S., Romagnoli G., Spadaro F., Canini I., Sirabella P., Borghi P., Ramoni C., Filesi I., Biocca S., Gabriele L., et al. LOX-1 as a natural IFN-alpha-mediated signal for apoptotic cell uptake and antigen presentation in dendritic cells. Blood 2010, 115:1554-1563.
31. Mahnke K., Guo M., Lee S., Sepulveda H., Swain S.L., Nussenzweig M., Steinman R.M. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J Cell Biol 2000, 151:673-684.
32. Bonifaz L., Bonnyay D., Mahnke K., Rivera M., Nussenzweig M.C., Steinman R.M. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med 2002, 196:1627-1638.
33. Sancho D., Mourao-Sa D., Joffre O.P., Schulz O., Rogers N.C., Pennington D.J., Carlyle J.R., Reis e Sousa C. Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. J Clin Invest 2008, 118:2098-2110.
34. Caminschi I., Proietto A.I., Ahmet F., Kitsoulis S., Shin Teh J., Lo J.C., Rizzitelli A., Wu L., Vremec D., van Dommelen S.L., et al. The dendritic cell subtype restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood 2008, 112:3264-3273.
35. Saba K., Denda-Nagai K., Irimura T. A C-type lectin MGL1/CD301a plays an anti-inflammatory role in murine experimental colitis. Am J Pathol 2009, 174:144-152.
36. Weck M.M., Appel S., Werth D., Sinzger C., Bringmann A., Grünebach F., Brossart P. hDectin-1 is involved in uptake and cross-presentation of cellular antigens. Blood 2008, 111:4264-4272.
37. Schoenen H., Bodendorfer B., Hitchens K., Manzanero S., Werninghaus K., Nimmerjahn F., Agger E.M., Stenger S., Andersen P., Ruland J., et al. Cutting edge: mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate. J Immunol 2010, 184:2756-2760.
38. Nakamura N., Shimaoka Y., Tougan T., Onda H., Okuzaki D., Zhao H., Fujimori A., Yabuta N., Nagamori I., Tanigawa A., et al. Isolation and expression profiling of genes upregulated in bone marrow-derived mononuclear cells of rheumatoid arthritis patients. DNA Res 2006, 13:169-183.
39. Steinman R.M., Turley S., Mellman I., Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000, 191:411-416.
40. Scaffidi P., Misteli T., Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418:191-195.
41. Shi Y., Evans J.E., Rock K.L. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003, 425:516-521.
42. Apetoh L., Ghiringhelli F., Tesniere A., Criollo A., Ortiz C., Lidereau R., Mariette C., Chaput N., Mira J.-P., Delaloge S., et al. The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunol Rev 2007, 220:47-59.
43. Ghiringhelli F., Apetoh L., Tesniere A., Aymeric L., Ma Y., Ortiz C., Vermaelen K., Panaretakis T., Mignot G., Ullrich E., et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 2009, 15:1170-1178.
44. Hirt U.A., Leist M. Rapid, noninflammatory and PS-dependent phagocytic clearance of necrotic cells. Cell Death Differ 2003, 10:1156-1164.
45. Scheffer S.R., Nave H., Korangy F., Schlote K., Pabst R., Jaffee E.M., Manns M.P., Greten T.F. Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo. Int J Cancer 2003, 103:205-211.
46. Brouckaert G., Kalai M., Krysko D.V., Saelens X., Vercammen D., Ndlovu M.N., Ndlovu a.M., Haegeman G., apos D., Herde K., Vandenabeele P. Phagocytosis of necrotic cells by macrophages is phosphatidylserine dependent and does not induce inflammatory cytokine production. Mol Biol Cell 2004, 15:1089-1100.
47. Gamrekelashvili J., Krüger C., von Wasielewski R., Hoffmann M., Huster K.M., Busch D.H., Manns M.P., Korangy F., Greten T.F. Necrotic tumor cell death in vivo impairs tumor-specific immune responses. J Immunol 2007, 178:1573-1580.
48. Lazzaro B.P., Rolff J. Immunology. Danger, microbes, and homeostasis. Science 2011, 332:43-44.
49. Rock K.L., Kono H. The inflammatory response to cell death. Annu Rev Pathol 2008, 3:99-126.
50. Elliott M.R., Ravichandran K.S. Clearance of apoptotic cells: implications in health and disease. J Cell Biol 2010, 189:1059-1070.
51. Mocarski E.S., Upton J.W., Kaiser W.J. Viral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways. Nat Rev Immunol 2011, 12:79-88.
52. Torchinsky M.B., Garaude J., Martin A.P., Blander J.M. Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature 2009, 458:78-82.